Market Place
Sourcing Support
All News #Library
Others
VolitionRx Secures EUR 2M Non-Dilutive Funding in Belgium
31 Mar 2026 //
PR NEWSWIRE
Volition Appoints New Distributor For Nu.Q Discover
10 Feb 2026 //
PR NEWSWIRE
Volition Sponsors Symposium at EHCF`s 15th Conference
04 Feb 2026 //
PR NEWSWIRE
Volition Continues To Extend Access To Nu.Q Vet Cancer Test
20 Jan 2026 //
PR NEWSWIRE
Volitionrx Sets $6M Pricing For Public Stock Offering
10 Oct 2025 //
PR NEWSWIRE
Volition Signs Co-Marketing And Services Agreement With Hologic
29 Sep 2025 //
PR NEWSWIRE
Volition Signs Global Supply Agreement for Nu.Q® Vet Cancer Test
20 Oct 2022 //
PRNEWSWIRE
Volition Announces U.S. Clinical Study for NETs
10 Aug 2022 //
PR NEWSWIRE
Volition appoints Sharon Ballesteros as Head of Quality, Development Process
06 Apr 2022 //
PRNEWSWIRE
VolitionRx Limited Announces Full Fiscal Year 2021 Financial Results
30 Mar 2022 //
PRNEWSWIRE
Volition Executes Supply & Licensing Contract for Nu.Q Vet Cancer Screening Test
16 Dec 2021 //
PRNEWSWIRE
VolitionRx Limited to Webcast Live at Life Sciences Investor Forum June 24th
21 Jun 2021 //
GLOBENEWSWIRE
VolitionRx Limited to Present at Conferences in March 2021
09 Mar 2021 //
PRNASIA
VolitionRx Announces Closing of $20 M Underwritten Public Offering
12 Feb 2021 //
PRNASIA
Copyright © 2026 LePro PharmaCompass OPC Private Limited, All rights reserved.